Evaluation of Smoking and Alcohol Consumption as Determinants of High Blood Pressure among People Living with HIV Receiving Antiretroviral Therapy in Zamfara

Download Article

DOI: 10.21522/TIJPH.2013.12.01.Art030

Authors : Nasiru Bala Zurmi, Bello Arkilla Magaji, Amitabye Luximon-Ramma

Abstract:

Non-communicable diseases have been reported among people living with HIV (PLWH). This cross-sectional study evaluated the role of smoking and alcohol consumption as potential determinants of high blood pressure among 424 PLWH receiving antiretroviral therapy (ART) in Zamfara. The study involved participants aged 18-60 years and above, with a higher female (70.3%) representation. Current smoking and alcohol use were recorded at 7.1% and 2.8% respectively, with higher rates among males. Meanwhile, the use of smokeless tobacco and exposure to second-hand smoke stood at 2.4% and 13.0% respectively. On average, systolic and diastolic blood pressure was found to be higher in males (128.8 and 86.1 mmHg respectively) than in females (125.0 and 85.3 mmHg respectively). Interestingly, raised blood pressure, defined as systolic BP  140 mmHg and/or diastolic BP  90 mmHg, was observed more frequently in females (23.4%) than males (11.7%). This discrepancy may be due to a higher number of female participants or other unidentified factors. The data suggest that while smoking and alcohol consumption among the PLWH under ART in Zamfara are not rampant, there is a mild association with high blood pressure. Further research is required to clarify the relationships between these behaviours and high blood pressure in this population. Public health strategies targeting modifiable risk factors such as smoking and alcohol consumption may assist in managing high blood pressure among PLWH receiving ART.


References:

[1] World Health Organization (WHO). (2021). Hypertension. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/hypertension.

[2] Forouzanfar, M. H., Liu, P., Roth, G. A., Ng, M., Biryukov, S., Marczak, L., & Murray, C. J. (2017). Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015. Jama, 317(2), 165-182.

[3] Hsue, P. Y., Hunt, P. W., Sinclair, E., Bredt, B., Franklin, A., Killian, M., & Deeks, S. G. (2018). Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS, 22(18), 2275-2283.

[4] UNAIDS. (2020). Global HIV & AIDS statistics — 2020 fact sheet. Retrieved from https://www.unaids.org/en/resources/fact-sheet.

[5] Palella Jr, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., ... & HIV Outpatient Study Investigators. (2022). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 338(13), 853-860.

[6] Freiberg, M. S., Chang, C. H., Skanderson, M., Patterson, O. V., DuVall, S. L., Brandt, C. A., & Kuller, L. H. (2019). Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study. JAMA cardiology, 4(4), 298-307.

[7] Boccara, F. (2018). Cardiovascular Health in an Aging HIV Population. AIDS, 27(8), 1303-1314.

[8] Dorjee, K., Baxi, S. M., Reingold, A. L., & Hubbard, A. (2020). Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study. BMC Infectious Diseases, 20, 655.

[9] Mills, K. T., Bundy, J. D., Kelly, T. N., Reed, J. E., Kearney, P. M., Reynolds, K., & He, J. (2016). Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation, 134(6), 441-450.

[10] O'Cleirigh, C., Valentine, S. E., Pinkston, M., Herman, D., Bedoya, C. A., Gordon, J. R., & Safren, S. A. (2015). The unique challenges facing HIV-positive patients who smoke cigarettes: HIV viremia, ART adherence, engagement in HIV care, and concurrent substance use. AIDS and Behavior, 19(1), 178-185.

[11] Mdodo, R., Frazier, E. L., Dube, S. R., Mattson, C. L., Sutton, M. Y., Brooks, J. T., & Skarbinski, J. (2015). Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Annals of internal medicine, 162(5), 335-344.

[12] Rahmanian, S., Wewers, M. E., Koletar, S., Reynolds, N., Ferketich, A., & Diaz, P. (2011). Cigarette smoking in the HIV-infected population. Proceedings of the American Thoracic Society, 8(3), 313-319.

[13] Tseng, Z. H., & Seet, R. C. (2019). Cardiovascular effects of HIV infection. Current Atherosclerosis Reports, 21(4), 15.

[14] Bello, G. A., Chipeta, J., & Aberle-Grasse, J. (2020). Assessment of trends in socio-demographic characteristics of persons living with HIV/AIDS receiving antiretroviral therapy in the public sector in northern Nigeria, 2004-2006. Journal of the International Association of Providers of AIDS Care (JIAPAC), 19, 2325958219880579.

[15] Remais, J. V., Zeng, G., Li, G., Tian, L., Engelgau, M. M. Convergence of non-communicable and infectious diseases in low-and middle-income countries. International journal of epidemiology, 2019, 42(1), 221-227.

[16] Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo Jr, J. L., & Roccella, E. J. (2003). The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Jama, 289(19), 2560-2572.

[17] Bloomfield, G. S., Hogan, J. W., Keter, A., Sang, E., Carter, E. J., Velazquez, E. J., & Kimaiyo, S. (2014). Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya. PloS one, 6(7), e22288.

[18] Freiberg, M. S., Chang, C. C., Kuller, L. H., Skanderson, M., Lowy, E., Kraemer, K. L., & Justice, A. C. (2013). HIV infection and the risk of acute myocardial infarction. JAMA Internal Medicine, 173(8), 614-622.

[19] World Health Organization (WHO). (2020). Body mass index - BMI. World Health Organization. https://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle.

[20] Pampel, F., Mollborn, S., & Lawrence, E. (2014). Life course transitions in early adulthood and SES disparities in tobacco use. Social Science Research, 43, 45-59.

[21] Levy, D., de Almeida, L. M., & Szklo, A. (2018). The Brazil SimSmoke policy simulation model: the effect of strong tobacco control policies on smoking prevalence and smoking-attributable deaths in a middle-income nation. PLoS Medicine, 9(11), e1001336.

[22] Yatsuya, H., Folsom, A. R., & ARIC Investigators. (2017). Risk of incident cardiovascular disease among users of smokeless tobacco in the Atherosclerosis Risk in Communities (ARIC) study. American Journal of Epidemiology, 174(6), 618-624.

[23] Yang, Y. H., Hsueh, K. C., & Chiou, W. K. (2015). Relationship between secondhand smoke and risk of metabolic syndrome in nonsmoking women. Clinical Nutrition, 34(3), 593-598.

[24] Anteneh, Z. A., Yalew, W. A., & Abitew, D. B. (2019). Prevalence and correlation of hypertension among adult HIV/AIDS patients in Gondar University Referral Hospital, northwest Ethiopia. HIV/AIDS (Auckland, N.Z.), 11, 133–140. https://doi.org/10.2147/HIV.S193730.

[25] Nwagu, E. N., Oyibo, P. G., & Nwagu, I. M. (2016). Prevalence and determinants of alcohol consumption among adult patients in Aminu Kano Teaching Hospital, Kano, Nigeria. Journal of Dental and Medical Sciences, 15(3), 97-101.

[26] Briasoulis, A., Agarwal, V., & Messerli, F. H. (2012). Alcohol consumption and the risk of hypertension in men and women: a systematic review and meta-analysis. The Journal of clinical hypertension, 14(11), 792-798.

[27] Justice, A. C., McGinnis, K. A., Tate, J. P., Braithwaite, R. S., Bryant, K. J., Cook, R. L., & Freiberg, M. S. (2016). Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men. Drug and alcohol dependence, 161, 95-103.

[28] NCD Risk Factor Collaboration (NCD-RisC). (2017). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. The Lancet, 389(10064), 37-55.

[29] Rabkin, M., Mutiti, A., Chung, C., Zhang, Y., Wei, Y., El-Sadr, W. M. (2021). High burden of hypertension across the HIV care continuum in sub-Saharan Africa: a systematic review. Journal of the International AIDS Society, 24(8), e25722.

[30] Spruill, T. M. (2010). Chronic psychosocial stress and hypertension. Current hypertension reports, 12(1), 10–16. https://doi.org/10.1007/s11906-009-0084-8.

[31] Noubiap, J. J., Nansseu, J. R., Nyaga, U. F., Sime, P. S., Francis, I., & Bigna, J. J. (2019). Global burden of hypertension among people living with HIV in the era of increased life expectancy: a systematic review and meta-analysis. Journal of Hypertension, 37(4), 696-705.